Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviridae | 6 | 2008 | 132 | 0.320 |
Why?
|
| Viral Vaccines | 4 | 2009 | 56 | 0.240 |
Why?
|
| Genetic Vectors | 7 | 2009 | 929 | 0.210 |
Why?
|
| Vaccines, Synthetic | 4 | 2009 | 80 | 0.150 |
Why?
|
| Smallpox Vaccine | 2 | 2009 | 11 | 0.140 |
Why?
|
| Vaccinia virus | 2 | 2009 | 69 | 0.140 |
Why?
|
| SAIDS Vaccines | 2 | 2008 | 21 | 0.130 |
Why?
|
| Adenoviridae Infections | 2 | 2007 | 5 | 0.120 |
Why?
|
| Capsid Proteins | 3 | 2006 | 107 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2008 | 679 | 0.100 |
Why?
|
| Cross Reactions | 3 | 2009 | 140 | 0.090 |
Why?
|
| Gene Products, gag | 3 | 2008 | 66 | 0.090 |
Why?
|
| Immunity, Cellular | 3 | 2009 | 170 | 0.090 |
Why?
|
| Neutralization Tests | 5 | 2009 | 126 | 0.080 |
Why?
|
| Macaca mulatta | 5 | 2009 | 263 | 0.070 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2006 | 84 | 0.070 |
Why?
|
| Smallpox | 1 | 2008 | 6 | 0.070 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 59 | 0.060 |
Why?
|
| Adenoviruses, Human | 1 | 2005 | 10 | 0.060 |
Why?
|
| Reassortant Viruses | 1 | 2005 | 10 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 186 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2006 | 114 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 6 | 2007 | 3504 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 642 | 0.050 |
Why?
|
| Immunization, Secondary | 3 | 2009 | 52 | 0.050 |
Why?
|
| Mice | 7 | 2008 | 11185 | 0.040 |
Why?
|
| Animals | 9 | 2009 | 21489 | 0.040 |
Why?
|
| Antigens, Viral | 2 | 2009 | 130 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2006 | 108 | 0.030 |
Why?
|
| Serotyping | 2 | 2007 | 52 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 449 | 0.030 |
Why?
|
| Immunization | 2 | 2008 | 135 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 329 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 869 | 0.030 |
Why?
|
| Defective Viruses | 1 | 2009 | 4 | 0.020 |
Why?
|
| Fowlpox virus | 1 | 2009 | 4 | 0.020 |
Why?
|
| Ectromelia virus | 1 | 2008 | 1 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 73 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2008 | 26 | 0.020 |
Why?
|
| Genetic Therapy | 2 | 2006 | 852 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2008 | 168 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2007 | 18 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2007 | 51 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 377 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 302 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 386 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 47 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2008 | 273 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 188 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 576 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 72 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 417 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 605 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 111 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 95 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 667 | 0.010 |
Why?
|
| Vaccines | 1 | 2006 | 97 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 291 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1332 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 323 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1980 | 0.010 |
Why?
|
| Humans | 2 | 2009 | 65826 | 0.010 |
Why?
|
| Female | 1 | 2006 | 34414 | 0.000 |
Why?
|